Please login to the form below

Horizon

This page shows the latest Horizon news and features for those working in and with pharma, biotech and healthcare.

UK government’s ‘science superpower’ ambitions to fail without clear plan, Lords committee warns

Horizon Europe and cuts to research funded by Official Development Assistance – a move which the peers said had already damaged the UK’s international reputation.

Latest news

Cancer Research UK urges government to realise ‘science superpower’ ambitions as new report highlights ‘huge’ economic value

The research follows the launch of Cancer Research Horizons, a new innovation engine built to complement the charity’s network of researchers by attracting more global private sector investment from pharma
Scientists discover new approach to treat brain tumours

A group of scientists from the University of Surrey have shared findings from a seven-year research study, revealing that a new approach could be on the horizon for treating one
Cancer Research UK drives innovation with Cancer Research Horizons

Cancer Research UK has revealed Cancer Research Horizons, its new approach to driving innovation in the development of new treatments for patients. ... partners. Additionally, Horizons will provide intellectual property advice, research commercialisation
Novartis UK launches local charity partnerships to support social mobility pledges

Novartis UK has teamed up with the Social Mobility Foundation and Founders4Schools, while also providing OnSide Youth Zones in White City – WEST Youth Zone – and Grimsby – Horizon Youth Zone – with financial
FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer

Advanced cervical cancer has also proved extremely difficult to treat. However, there is good news on the horizon for the 15, 000 women diagnosed with the disease each year in the

More from news
Approximately 18 fully matching, plus 156 partially matching documents found.

Latest Intelligence

The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence

The new era of DCT, combined with the advance of AI, expands the horizon for patient identification beyond traditional site-based models.
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed

A year later, with vaccine approvals and distribution underway, hope is on the horizon.
Setting up for success in a post-Brexit, post-pandemic Britain

above all, hope that a way through the pandemic is on the horizon.
Reaching patients and HCPs during the pandemic

Horizon already had digital promotional materials at the ready, and that foresight helped the company to mitigate the damage caused by COVID-19. ... Since the launch, Horizon has revised its projected sales of Tepezza from $30m-$40m to around $200m.
Medicinal data – what’s next for IDMP?

have relied on a hard compliance date remaining on the distant horizon.

More from intelligence
Approximately 0 fully matching, plus 61 partially matching documents found.

Latest appointments

CureVac’s CEO appointed to EC High Level Group

Dr Ingmar Hoerr will advise on Horizon 2020 and future innovation programmes. ... Dr Hoerr joins a panel of 15 group members who will advise the EC on how to strengthen support for breakthrough, market-creating innovation in the Horizon 2020 project as
Decibel Therapeutics expands leadership team

He co-founded Bright Horizons Family Solutions, a worksite childcare and early education provider, and prior to this served as co-director of Save the Children's Sudan operations.
Eric Rhodes becomes CEO of ERS Genomics

Rhodes joins ERS Genomics from Horizon Discovery, where he served as senior vice president of research and development and chief technology officer. ... Prior to joining Horizon Discovery, Rhodes held a number of senior positions including director of
Jane Osbourn to chair BIA board

The new members of the board are Darrin Disley, chief executive of Horizon Discovery Group and David Hipkiss, chief business officer at Circassia Pharmaceuticals.
Adaptimmune appoints Lawrence Alleva to its board

He currently serves as a director for public companies Tesaro and Bright Horizons Family Solutions, and for the privately-held Mirna Therapeutics, and chairs those companies' audit committees.

More from appointments
Approximately 3 fully matching, plus 10 partially matching documents found.

Latest from PMHub

Welcome to the era of the orphan drug

Thankfully, owing to the considerable research efforts of the global scientific community, vaccines have been rolled-out and the promise of normality is on the horizon.
We Need To Talk About We Don’t Talk About Bruno

The princess (literal or otherwise) stares at the horizon and sings about the life she wants.
Future focus: 3 tools for launching fast in the face of uncertainty

You could see the barriers that would impact your clinical trials, the siloes slowing down decision making, and even look far into the horizon to understand how your product launch would
Is COVID-19 yet another barrier to contraceptive access?

12. If a big change in contraceptive trends is on the horizon, then there needs to be professional advice available.
A day in the life of a PR Account Director

Organise and encourage! PR can be fast paced so organisation is key to ensuring everything is covered, while also keeping a keen eye on the horizon for what is coming next.